首页> 外文期刊>Cell Reports >Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis
【24h】

Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis

机译:定量多重免疫组织化学揭示了骨髓内发炎的肿瘤免疫复杂性与预后差相关的肿瘤免疫复杂性

获取原文
           

摘要

Here, we describe a multiplexed immunohistochemical platform with computational image processing workflows, including image cytometry, enabling simultaneous evaluation of 12 biomarkers in one formalin-fixed paraffin-embedded tissue section. To validate this platform, we used tissue microarrays containing 38 archival head and neck squamous cell carcinomas and revealed differential immune profiles based on lymphoid and myeloid cell densities, correlating with human papilloma virus status and prognosis. Based on these results, we investigated 24 pancreatic ductal adenocarcinomas from patients who received neoadjuvant GVAX vaccination and revealed that response to therapy correlated with degree of mono-myelocytic cell density and percentages of CD8^+ T cells expressing T cell exhaustion markers. These data highlight the utility of in situ immune monitoring for patient stratification and provide digital image processing pipelines to the community for examining immune complexity in precious tissue sections, where phenotype and tissue architecture are preserved to improve biomarker discovery and assessment.
机译:这里,我们描述了一种多路复用的免疫组化平台,其具有计算图像处理工作流程,包括图像细胞术,使得在一个福尔马林固定的石蜡包埋的组织部分中同时评估12个生物标志物。为了验证该平台,我们使用含有38个归档头和颈部鳞状细胞癌的组织微阵列,并根据淋巴和骨髓细胞密度揭示差异免疫型材,与人乳头瘤病毒状态和预后相关。基于这些结果,我们研究了接受Neoadjuvant Gvax疫苗接种的患者的24例胰腺导管腺癌,并揭示了对治疗的反应与表达T细胞耗尽标记的CD8 + T细胞的百分比相关。这些数据突出了原位免疫监测对患者分层的实用性,并为社区提供数字图像处理管道,以检查珍贵组织切片中的免疫复杂性,其中保存表型和组织结构以改善生物标志物发现和评估。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号